RELPAX
BGP PHARMA ULC
Quick answers
Is there a shortage of RELPAX in Canada?
No. There is no current shortage of RELPAX 40MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-ELETRIPTAN TABLETS
APOTEX INC
Other Products
TEVA-ELETRIPTAN
TEVA CANADA LIMITED
APO-ELETRIPTAN
APOTEX INC
PRO-ELETRIPTAN
PRO DOC LIMITEE
ELETRIPTAN
SANIS HEALTH INC
JAMP ELETRIPTAN
JAMP PHARMA CORPORATION
DIN
02256304
Strength
40MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
ELETRIPTAN (ELETRIPTAN HYDROBROMIDE)
See all ELETRIPTAN (ELETRIPTAN HYDROBROMIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.